[
    [
        {
            "time": "2020-04-27",
            "original_text": "华大基因：签不超2.65亿美元海外合同，将提供新冠病毒检测综合解决方案",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠病毒",
                    "检测",
                    "海外合同",
                    "综合解决方案"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：签不超2.65亿美元海外合同，将提供新冠病毒检测综合解决方案",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-26",
            "original_text": "华大基因：全资子公司与沙特公司在香港签订了《产品买卖和服务协议》",
            "features": {
                "keywords": [
                    "华大基因",
                    "全资子公司",
                    "沙特公司",
                    "产品买卖和服务协议",
                    "香港"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "国际合作"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：全资子公司与沙特公司在香港签订了《产品买卖和服务协议》",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-27",
            "original_text": "A股异动 | 华大基因涨逾6%，全资子公司与沙特NUPCO签2.65亿美元产品买卖和服务协议",
            "features": {
                "keywords": [
                    "A股",
                    "华大基因",
                    "沙特NUPCO",
                    "产品买卖和服务协议"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股异动 | 华大基因涨逾6%，全资子公司与沙特NUPCO签2.65亿美元产品买卖和服务协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-04-27",
            "original_text": "【国信证券】海外疫情持续蔓延，新冠检测试剂需求大增（周观点）",
            "features": {
                "keywords": [
                    "国信证券",
                    "海外疫情",
                    "新冠检测试剂",
                    "需求大增"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国信证券】海外疫情持续蔓延，新冠检测试剂需求大增（周观点）",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-27",
            "original_text": "医联联合华大基因上线核酸检测服务：可线上预约，检测费240元",
            "features": {
                "keywords": [
                    "医联",
                    "华大基因",
                    "核酸检测",
                    "线上预约",
                    "检测费"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "健康服务"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医联联合华大基因上线核酸检测服务：可线上预约，检测费240元",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]